BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18202976)

  • 1. Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics.
    Campioni D; Lanza F; Moretti S; Ferrari L; Cuneo A
    Cytotherapy; 2008; 10(1):69-82. PubMed ID: 18202976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression.
    Montesinos JJ; Flores-Figueroa E; Castillo-Medina S; Flores-Guzmán P; Hernández-Estévez E; Fajardo-Orduña G; Orozco S; Mayani H
    Cytotherapy; 2009; 11(2):163-76. PubMed ID: 19152152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.
    Poloni A; Maurizi G; Rosini V; Mondini E; Mancini S; Discepoli G; Biasio S; Battaglini G; Felicetti S; Berardinelli E; Serrani F; Leoni P
    Cytotherapy; 2009; 11(2):153-62. PubMed ID: 19301169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.
    Kaiser S; Hackanson B; Follo M; Mehlhorn A; Geiger K; Ihorst G; Kapp U
    Cytotherapy; 2007; 9(5):439-50. PubMed ID: 17786605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs.
    Campioni D; Rizzo R; Stignani M; Melchiorri L; Ferrari L; Moretti S; Russo A; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Cuneo A; Baricordi OR; Lanza F
    Cytometry B Clin Cytom; 2009 May; 76(3):225-30. PubMed ID: 18985728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood.
    Manca MF; Zwart I; Beo J; Palasingham R; Jen LS; Navarrete R; Girdlestone J; Navarrete CV
    Cytotherapy; 2008; 10(1):54-68. PubMed ID: 18202975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects.
    Sanchez-Guijo FM; Blanco JF; Cruz G; Muntion S; Gomez M; Carrancio S; Lopez-Villar O; Barbado MV; Sanchez-Abarca LI; Blanco B; Briñon JG; del Cañizo MC
    Cell Tissue Res; 2009 Jun; 336(3):501-7. PubMed ID: 19357871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients.
    Coipeau P; Rosset P; Langonne A; Gaillard J; Delorme B; Rico A; Domenech J; Charbord P; Sensebe L
    Cytotherapy; 2009; 11(5):584-94. PubMed ID: 19626496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: limitations for autologous cell replacement strategies.
    Hermann A; List C; Habisch HJ; Vukicevic V; Ehrhart-Bornstein M; Brenner R; Bernstein P; Fickert S; Storch A
    Cytotherapy; 2010; 12(1):17-30. PubMed ID: 19878082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro.
    Stadler G; Hennerbichler S; Lindenmair A; Peterbauer A; Hofer K; van Griensven M; Gabriel C; Redl H; Wolbank S
    Cytotherapy; 2008; 10(7):743-52. PubMed ID: 18985480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilineage differentiation potential of human dermal skin-derived fibroblasts.
    Lorenz K; Sicker M; Schmelzer E; Rupf T; Salvetter J; Schulz-Siegmund M; Bader A
    Exp Dermatol; 2008 Nov; 17(11):925-32. PubMed ID: 18557932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains.
    Barzilay R; Sadan O; Melamed E; Offen D
    Cytotherapy; 2009; 11(4):435-42. PubMed ID: 19521891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.
    Stute N; Holtz K; Bubenheim M; Lange C; Blake F; Zander AR
    Exp Hematol; 2004 Dec; 32(12):1212-25. PubMed ID: 15588946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study.
    Kurt Yüksel M; Topçuoğlu P; Kurdal M; Ilhan O
    Cytotherapy; 2010; 12(1):38-44. PubMed ID: 19878078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic changes of human articular chondrocytes during monolayer culture reflect bona fide dedifferentiation rather than amplification of progenitor cells.
    Diaz-Romero J; Nesic D; Grogan SP; Heini P; Mainil-Varlet P
    J Cell Physiol; 2008 Jan; 214(1):75-83. PubMed ID: 17559082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media.
    Turnovcova K; Ruzickova K; Vanecek V; Sykova E; Jendelova P
    Cytotherapy; 2009; 11(7):874-85. PubMed ID: 19903100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.
    Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F
    J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
    Bieback K; Hecker A; Kocaömer A; Lannert H; Schallmoser K; Strunk D; Klüter H
    Stem Cells; 2009 Sep; 27(9):2331-41. PubMed ID: 19544413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.